| Literature DB >> 21745500 |
Kazuhiko Akuzawa1, Rie Yamada, Zhuan Li, Ying Li, Hidetaka Sadanari, Keiko Matsubara, Kunitomo Watanabe, Mamoru Koketsu, Yuuzo Tuchida, Tsugiya Murayama.
Abstract
The anti-human cytomegalovirus (HCMV) activity of tricin (4',5,7-trihydroxy-3',5'-dimethoxyflavone), a derivative from Sasa albo-marginata, was studied in the human embryonic fibroblast cell line MRC-5. In a plaque assay, tricin and ganciclovir (GCV) showed concentration-dependent inhibitory properties from 0.05 to 3.6 μM and 0.01 to 1.0 μM, respectively. Tricin had no virucidal effects on cell-free HCMV. Treatment with tricin 1h before, or 1h or 3h after viral infection significantly suppressed HCMV replication. Moreover, tricin inhibited the expression of immediate early (IE) 2 mRNA and DNA polymerase (UL54) mRNA in HCMV-infected cells. Western blot analysis also demonstrated that tricin decreased the expression of IE antigen (especially IE2) and cyclooxygenase 2 (COX-2) expression in HCMV-infected cells. In the presence of tricin, prostaglandin E2 (PGE2) accumulation by HCMV infection was completely inhibited. These results suggest that tricin is a novel compound with potential COX inhibitor-dependent anti-HCMV activity. CrownEntities:
Mesh:
Substances:
Year: 2011 PMID: 21745500 DOI: 10.1016/j.antiviral.2011.06.014
Source DB: PubMed Journal: Antiviral Res ISSN: 0166-3542 Impact factor: 5.970